Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Prostatic Neoplasms 4Neuroendocrine Tumors 2Lymphoma 2Hodgkin Disease 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Smoking Cessation 1Rectal Neoplasms 1Prostate Cancer Metastatic 1Neoplastic Cells, Circulating 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Multiple Pulmonary Nodules 1Multiple Myeloma 1Mouth Neoplasms 1Lymphoma, T-Cell 1Lymphoma, B-Cell 1Leukemia 1Hypoxia 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Lobular 1Cancer Diagnosis 1Brain Neoplasms 1Adenocarcinoma 1

Interventions

Cyclophosphamide 115fludarabine phosphate 67Mycophenolic Acid 62Etoposide 61Peripheral Blood Stem Cell Transplantation 58Tacrolimus 55Melphalan 48Filgrastim 48Busulfan 48Whole-Body Irradiation 47Doxorubicin 46Radiotherapy 42fludarabine 38Cyclosporine 38Brentuximab Vedotin 38Vinblastine 35Granulocyte Colony-Stimulating Factor 35Antilymphocyte Serum 30Methotrexate 29Dacarbazine 29Gemcitabine 28Rituximab 26Nivolumab 25Prednisone 24Bleomycin 24Vincristine 22pembrolizumab 21Carmustine 21Cytarabine 20thymoglobulin 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Hodgkin Disease × Positron Emission Tomography Computed Tomography × Clear all
NCT03615664 2025-01-16

BURGUND

Polish Lymphoma Research Group

Phase 2 Completed
115 enrolled
Lymphoid

Hodgkin Disease, Lymphoma

NCT01390584 2023-06-29

Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma

Eastern Cooperative Oncology Group

Phase 2 Terminated
6 enrolled 9 charts
Lymphoid

Hodgkin Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡